Pediatric Nephrology

, Volume 27, Issue 6, pp 933–939 | Cite as

Outcome of Henoch–Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset

  • Outi Jauhola
  • Jaana Ronkainen
  • Olli Koskimies
  • Marja Ala-Houhala
  • Pekka Arikoski
  • Tuula Hölttä
  • Timo Jahnukainen
  • Jukka Rajantie
  • Timo Örmälä
  • Matti NuutinenEmail author
Original Article



Corticosteroids have been shown not to prevent the development of Henoch–Schönlein nephritis. However, long-term follow-up data are scarce.


The long-term outcome of patients in a randomized placebo-controlled prednisone study was evaluated 8 years later with a health questionnaire completed by 160/171 (94%) patients and by urine and blood pressure screening (138/171, 81%).


Twelve patients had hematuria and/or proteinuria and seven had hypertension. The patients with nephritis at onset of Henoch–Schönlein purpura (HSP) had an increased risk of hypertension and/or urine abnormalities (odds ratio 3.6, p = 0.022, 95% confidence interval 1.3–10.0). There were no differences between the prednisone and placebo groups. Recurrences of purpura were reported by 15 patients, with some recurrences continuing for 10 years. All five reported pregnancies were complicated by proteinuria. Four patients presented with hematuria and/or proteinuria at the control visit, and four had hypertension. Of these, two had a decreased estimated glomerular filtration rate.


HSP has a good long-term prognosis in unselected patients, although skin relapses with/without late-onset nephritis may occur, even a decade after the initial disease. Urine and blood pressure abnormalities 8 years after HSP are associated with nephritis at its onset. Early prednisone treatment does not affect the outcome and should not be routinely used.


Vasculitis Glomerulonephritis Hypertension Recurrences Pregnancy Familial cases Corticosteroids 



We thank Helena Moilanen, a registered nurse, for helping in organizing the laboratory tests throughout the country. We also thank all of the health care centers and hospitals that helped us by screening the patients for this study. This work was supported by grants from the Alma and K. A. Snellman Foundation, Oulu, Finland, and the Finnish Kidney and Liver Association.


  1. 1.
    Weiss P, Klink A, Hexem K, Burnham J, Leonard M, Keren R, Localio R, Feudtner C (2009) Variation in inpatient therapy and diagnostic evaluation of children with Henoch Schönlein purpura. J Pediatr 155:812–818.e1PubMedCrossRefGoogle Scholar
  2. 2.
    Ozen S, Pistorio A, Iusan S, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario M, Silva C, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella A, Olivieri A, Alpigiani M, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798–806PubMedCrossRefGoogle Scholar
  3. 3.
    Saulsbury F (1999) Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 78:395–409CrossRefGoogle Scholar
  4. 4.
    Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Hölttä T, Jahnukainen T, Rajantie J, Örmälä T, Nuutinen M (2010) Clinical course of extrarenal symptoms in Henoch-Schönlein purpura: A 6-month prospective study. Arch Dis Child 95:871–876PubMedCrossRefGoogle Scholar
  5. 5.
    Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood Henoch-Schönlein purpura: A retrospective cohort study. Lancet 360:666–670PubMedCrossRefGoogle Scholar
  6. 6.
    Koskimies O, Rapola J, Savilahti E, Vilska J (1974) Renal involvement in Schönlein-Henoch purpura. Acta Paediatr Scand 63:357–363PubMedCrossRefGoogle Scholar
  7. 7.
    Chartapisak W, Opastirakul S, Hodson E, Willis N, Craig J (2009) Interventions for preventing and treating kidney disease in Henoch-Schönlein purpura (HSP). Cochrane Database Syst Rev 2009:005128Google Scholar
  8. 8.
    Dudley J, Smith G, Llewellyn-Edwards A, Tizard E (2007) Randomised placebo controlled trial to assess the role of early prednisolone on the development and progression of Henoch-Schönlein purpura nephritis (abstract). Pediatr Nephrol 22:1457Google Scholar
  9. 9.
    Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Örmälä T, Turtinen J, Nuutinen M (2006) Early prednisone therapy in Henoch-Schönlein purpura: A randomized, double-blind, placebo-controlled trial. J Pediatr 149:241–247PubMedCrossRefGoogle Scholar
  10. 10.
    Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Hölttä T, Jahnukainen T, Rajantie J, Örmälä T, Turtinen J, Nuutinen M (2010) Renal manifestations of Henoch-Schönlein purpura in a 6-month prospective study of 223 children. Arch Dis Child 95:877–882PubMedCrossRefGoogle Scholar
  11. 11.
    European Confederation of Laboratory M (2000) European urinalysis guidelines. Scand J Clin Lab Invest Suppl 231:1–96Google Scholar
  12. 12.
    National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (1996) Update on the 1987 task force report on high blood pressure in children and adolescents: A working group report from the National High Blood Pressure Education Program. Pediatrics 98:649–658Google Scholar
  13. 13.
    Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637PubMedCrossRefGoogle Scholar
  14. 14.
    Goldstein AR, White RH, Akuse R, Chantler C (1992) Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 339:280–282PubMedCrossRefGoogle Scholar
  15. 15.
    Schärer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F (1999) Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr Nephrol 13:816–823PubMedCrossRefGoogle Scholar
  16. 16.
    Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F (2007) Clinical outcome in children with Henoch-Schönlein nephritis. Pediatr Nephrol 22:64–70PubMedCrossRefGoogle Scholar
  17. 17.
    Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L (2006) Predictors of outcome in Henoch-Schönlein nephritis in children and adults. Am J Kidney Dis 47:993–1003PubMedCrossRefGoogle Scholar
  18. 18.
    Edström Halling SF, Söderberg MP, Berg UB (2005) Henoch Schönlein nephritis: Clinical findings related to renal function and morphology. Pediatr Nephrol 20:46–51CrossRefGoogle Scholar
  19. 19.
    Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C (1977) Prognosis of Henoch-Schönlein nephritis in children. Br Med J 2:11–14PubMedCrossRefGoogle Scholar
  20. 20.
    Stewart M, Savage JM, Bell B, McCord B (1988) Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population. Eur J Pediatr 147:113–115PubMedCrossRefGoogle Scholar
  21. 21.
    Fretzayas A, Sionti I, Moustaki M, Papadimitriou A, Nicolaidou P (2008) Henoch-Schönlein purpura: A long-term prospective study in Greek children. J Clin Rheumatol 14:324–331PubMedCrossRefGoogle Scholar
  22. 22.
    Garcia-Porrua C, Calvino MC, Llorca J, Couselo JM, Gonzalez-Gay MA (2002) Henoch-Schönlein purpura in children and adults: Clinical differences in a defined population. Semin Arthritis Rheum 32:149–156PubMedCrossRefGoogle Scholar
  23. 23.
    Calvino M, Llorca J, Garcia-Porrua C, Fernandez-Iglesias J, Rodriguez-Ledo P, Gonzalez-Gay M (2001) Henoch-Schönlein purpura in children from Northwestern Spain: A 20-year epidemiologic and clinical study. Medicine (Baltimore) 80:279–290CrossRefGoogle Scholar
  24. 24.
    Koskimies O, Mir S, Rapola J, Vilska J (1981) Henoch-Schönlein nephritis: Long-term prognosis of unselected patients. Arch Dis Child 56:482–484PubMedCrossRefGoogle Scholar
  25. 25.
    Alfredo CS, Nunes NA, Len CA, Barbosa CM, Terreri MT, Hilario MO (2007) Henoch-Schönlein purpura: Recurrence and chronicity. J Pediatr (Rio J) 83:177–180CrossRefGoogle Scholar
  26. 26.
    Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, De Martino M (2005) Henoch Schönlein purpura in childhood: Epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 35:143–153PubMedCrossRefGoogle Scholar
  27. 27.
    Prais D, Amir J, Nussinovitch M (2007) Recurrent Henoch-Schönlein purpura in children. J Clin Rheumatol 13:25–28PubMedCrossRefGoogle Scholar
  28. 28.
    Allen D, Diamond L, Howell D (1960) Anaphylactoid purpura in children (Schönlein-Henoch syndrome): Review with a follow-up of the renal complications. AMA J Dis Child 99:833–854PubMedGoogle Scholar
  29. 29.
    Zhang Y, Gu W, Mao J (2008) Sibling cases of Henoch-Schönlein purpura in two families and review of literature. Pediatr Dermatol 25:393–395PubMedCrossRefGoogle Scholar
  30. 30.
    Montoliu J, Lens XM, Torras A, Revert L (1990) Henoch-Schönlein purpura and IgA nephropathy in father and son. Nephron 54:77–79PubMedCrossRefGoogle Scholar
  31. 31.
    Motoyama O, Iitaka K (2005) Familial cases of Henoch-Schönlein purpura in eight families. Pediatr Int 47:612–615PubMedCrossRefGoogle Scholar
  32. 32.
    Lau K, Suzuki H, Novak J, Wyatt R (2010) Pathogenesis of Henoch-Schönlein purpura nephritis. Pediatr Nephrol 25:19–26PubMedCrossRefGoogle Scholar
  33. 33.
    Saulsbury F (2010) Henoch-Schönlein purpura. Curr Opin Rheumatol 22:598–602PubMedCrossRefGoogle Scholar
  34. 34.
    Mollica F, Li Volti S, Garozzo R, Russo G (1992) Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 151:140–144PubMedCrossRefGoogle Scholar
  35. 35.
    Huber A, King J, McLaine P, Klassen T, Pothos M (2004) A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein purpura. BMC Med 2:7PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2012

Authors and Affiliations

  • Outi Jauhola
    • 1
  • Jaana Ronkainen
    • 2
  • Olli Koskimies
    • 3
  • Marja Ala-Houhala
    • 4
  • Pekka Arikoski
    • 5
  • Tuula Hölttä
    • 3
  • Timo Jahnukainen
    • 3
  • Jukka Rajantie
    • 6
  • Timo Örmälä
    • 7
  • Matti Nuutinen
    • 1
    Email author
  1. 1.Department of Children and AdolescentsOulu University HospitalOuluFinland
  2. 2.Oulu City Health Care CentreOuluFinland
  3. 3.Children’s HospitalUniversity of Helsinki and Helsinki University Central HospitalHelsinkiFinland
  4. 4.Department of PediatricsTampere University HospitalTampereFinland
  5. 5.Department of PediatricsKuopio University HospitalKuopioFinland
  6. 6.Department of Pediatrics, Jorvi HospitalHelsinki University Central HospitalEspooFinland
  7. 7.Department of PediatricsHyvinkää HospitalHyvinkääFinland

Personalised recommendations